These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 8739117)
21. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Gold PW; Chrousos G; Kellner C; Post R; Roy A; Augerinos P; Schulte H; Oldfield E; Loriaux DL Am J Psychiatry; 1984 May; 141(5):619-27. PubMed ID: 6324597 [TBL] [Abstract][Full Text] [Related]
22. A neurodevelopmental model for anorexia nervosa. Connan F; Campbell IC; Katzman M; Lightman SL; Treasure J Physiol Behav; 2003 Jun; 79(1):13-24. PubMed ID: 12818706 [TBL] [Abstract][Full Text] [Related]
23. The corticotropin-releasing hormone challenge in depressed abused, depressed nonabused, and normal control children. Kaufman J; Birmaher B; Perel J; Dahl RE; Moreci P; Nelson B; Wells W; Ryan ND Biol Psychiatry; 1997 Oct; 42(8):669-79. PubMed ID: 9325560 [TBL] [Abstract][Full Text] [Related]
24. Steroids and neuroendocrine function in anorexia nervosa. Casanueva FF; Borras CG; Burguera B; Muruais C; Fernández M; Devesa J J Steroid Biochem; 1987; 27(1-3):635-40. PubMed ID: 3121928 [TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of the diagnostic use and assay of corticotropin-releasing hormone in the physiopathologic state of the hypothalamo-pituitary-adrenal axis]. Nishikawa T; Yoshida A; Mikami K; Tamura Y; Yoshida S Nihon Rinsho; 1990 Feb; 48 Suppl():182-4. PubMed ID: 2162415 [No Abstract] [Full Text] [Related]
26. Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer. Jehn CF; Kühnhardt D; Bartholomae A; Pfeiffer S; Schmid P; Possinger K; Flath BC; Lüftner D Integr Cancer Ther; 2010 Sep; 9(3):270-5. PubMed ID: 20702499 [TBL] [Abstract][Full Text] [Related]
27. Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol. Abelson JL; Curtis GC; Cameron OG J Psychiatr Res; 1996; 30(2):79-93. PubMed ID: 8816303 [TBL] [Abstract][Full Text] [Related]
28. The endocrinology of anorexia nervosa and bulimia nervosa. Newman MM; Halmi KA Neurol Clin; 1988 Feb; 6(1):195-212. PubMed ID: 3288860 [TBL] [Abstract][Full Text] [Related]
29. Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis. Mello AF; Mello MF; Carpenter LL; Price LH Braz J Psychiatry; 2003 Oct; 25(4):231-8. PubMed ID: 15328550 [TBL] [Abstract][Full Text] [Related]
30. Relationship between weight gain and hypothalamic pituitary adrenal function in patients with anorexia nervosa. Doerr P; Fichter M; Pirke KM; Lund R J Steroid Biochem; 1980 May; 13(5):529-37. PubMed ID: 7392629 [No Abstract] [Full Text] [Related]
31. Diurnal patterns of salivary cortisol and DHEA in adolescent anorexia nervosa. Oskis A; Loveday C; Hucklebridge F; Thorn L; Clow A Stress; 2012 Nov; 15(6):601-7. PubMed ID: 22356124 [TBL] [Abstract][Full Text] [Related]
33. Variability in the secretion of corticotropin-releasing hormone, adrenocorticotropic hormone and cortisol and understandability of the hypothalamic-pituitary-adrenal axis dynamics--a mathematical study based on clinical evidence. Bairagi N; Chatterjee S; Chattopadhyay J Math Med Biol; 2008 Mar; 25(1):37-63. PubMed ID: 18343885 [TBL] [Abstract][Full Text] [Related]
34. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone. Schroeder S; Wichers M; Klingmüller D; Höfer M; Lehmann LE; von Spiegel T; Hering R; Putensen C; Hoeft A; Stüber F Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311 [TBL] [Abstract][Full Text] [Related]
35. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Gold PW; Licinio J; Wong ML; Chrousos GP Ann N Y Acad Sci; 1995 Dec; 771():716-29. PubMed ID: 8597444 [TBL] [Abstract][Full Text] [Related]
36. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression. Holsboer F; von Bardeleben U; Wiedemann K; Müller OA; Stalla GK Biol Psychiatry; 1987 Feb; 22(2):228-34. PubMed ID: 3028512 [No Abstract] [Full Text] [Related]
37. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Rinne T; de Kloet ER; Wouters L; Goekoop JG; DeRijk RH; van den Brink W Biol Psychiatry; 2002 Dec; 52(11):1102-12. PubMed ID: 12460693 [TBL] [Abstract][Full Text] [Related]
38. Ovine corticotropin-releasing hormone stimulation test in patients with chronic renal failure: pharmacokinetic properties, and plasma adrenocorticotropic hormone and serum cortisol responses. Siamopoulos KC; Eleftheriades EG; Pappas M; Sferopoulos G; Tsolas O Horm Res; 1988; 30(1):17-21. PubMed ID: 2851525 [TBL] [Abstract][Full Text] [Related]
39. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature]. Tajima-Pozo K; Montes-Montero A; Güemes I; González-Vives S; Díaz-Marsá M; Carrasco JL Endocrinol Nutr; 2013; 60(7):396-403. PubMed ID: 23623464 [TBL] [Abstract][Full Text] [Related]